Generate professional replies to Show Cause Notices, assessment orders, audit objections, and other legal communications using TaxTMI's AI Drafter.
Step 1 – Issue Identification & Review
The AI analyses your query, notice, order, or uploaded documents and identifies the key issues involved.
• Review the issues identified by the AI • Add, edit, remove, or refine issues as required
Step 2 – Draft Generation
Once you approve the issues, the AI performs issue-wise legal research and prepares a structured draft response.
• Relevant statutory provisions • Judicial precedents and Supreme Court, High Court and other citations • Issue-wise legal analysis • Practical arguments and supporting content • Professionally structured draft ready for further review.
Manufacturer's Supply of Drug Master File Not Taxable as Scientific Consultancy The Tribunal ruled that the supply of drug master file/technical package by a manufacturer of bulk drugs to buyers did not attract service tax liability ...
Cases where this provision is explicitly mentioned in the judgment/order text; may not be exhaustive. To view the complete list of cases mentioning this section, Click here.
Provisions expressly mentioned in the judgment/order text.
Manufacturer's Supply of Drug Master File Not Taxable as Scientific Consultancy
The Tribunal ruled that the supply of drug master file/technical package by a manufacturer of bulk drugs to buyers did not attract service tax liability under "Scientific or Technical Consultancy Services." The appellant's supply of data/information from these files was considered exclusive to buyers and not for transfer, distinguishing them from scientific or technology institutions. Precedents established that technical assistance by manufacturers did not fall under scientific or technical consultancy services, as they were not scientists or technocrats but experts related to their products. The Tribunal set aside the lower authorities' decision, allowing the appeal with any consequential relief.
Issues: 1. Whether the supply of drug master file/technical package attracts service tax liability under "Scientific or Technical Consultancy Services."
Analysis: The appeal challenged an Order-in-Appeal passed by the Commissioner of Central Excise, Pune. The appellant, a manufacturer of bulk drugs, created a "drug master file and technical package" for the bulk drugs they produced, providing copies to purchasers. Lower authorities alleged the appellant supplied data/information from these files for consideration, categorizing it as "Scientific or Technical Consultancy Services," imposing demands and penalties. The appellant contended that the supply was exclusive to buyers, not for transfer, and argued against being classified as a scientific or technology institution. Reference was made to precedents where manufacturers were not considered under this category. The Departmental Representative supported the lower authorities' findings, emphasizing technical assistance provided indirectly through the files.
Upon reviewing submissions and records, the Tribunal analyzed whether supplying the files to buyers incurred service tax liability under "Scientific or Technical Consultancy Services." The definition under Section 65(92) of the Finance Act, 1994, required services to be rendered by scientists, technocrats, or science/technology institutions to a client in science/technology disciplines. The Tribunal found the appellant, a manufacturer, did not fit this category, citing precedents like Ruchi Infotech Ltd. and Steelcast Ltd. where similar situations were examined. The judgments highlighted that technical assistance by manufacturers did not fall under scientific or technical consultancy services, as they were not scientists or technocrats but manufacturers providing expertise related to their products.
In the case of Steelcast Ltd., services provided by a manufacturer were deemed administrative, management, or legal/professional, falling under management consultant services rather than scientific or technical consultancy. The Tribunal clarified that management consultancy could be provided by any person, unlike scientific or technical consultancy requiring scientists or technocrats. As the appellant was a manufacturer of bulk drugs and not a scientist or technocrat, the impugned order was deemed unsustainable. Consequently, the Tribunal set aside the order, allowing the appeal with any consequential relief.
Full Summary is available for active users!
Note: It is a system-generated summary and is for quick reference only.